|
UTRN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40049999999936E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.697890E-03 |
| Normal-vs-Stage2 |
4.786300E-04 |
| Normal-vs-Stage3 |
8.44590000048662E-07 |
| Normal-vs-Stage4 |
7.53889994875578E-09 |
| Stage1-vs-Stage2 |
8.601900E-02 |
| Stage1-vs-Stage3 |
4.839600E-04 |
| Stage1-vs-Stage4 |
2.94649999954544E-07 |
| Stage2-vs-Stage3 |
6.406800E-01 |
| Stage2-vs-Stage4 |
1.171980E-01 |
| Stage3-vs-Stage4 |
9.438100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.78500000000059E-05 |
| Normal-vs-AfricanAmerican |
5.232800E-04 |
| Normal-vs-Asian |
3.602200E-01 |
| Caucasian-vs-AfricanAmerican |
5.749800E-01 |
| Caucasian-vs-Asian |
5.020800E-01 |
| AfricanAmerican-vs-Asian |
4.597400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59155999999161E-05 |
| Normal-vs-Female |
4.753700E-04 |
| Male-vs-Female |
1.488830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.213900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.440820E-04 |
| Normal-vs-Age(61-80Yrs) |
4.61990000000245E-06 |
| Normal-vs-Age(81-100Yrs) |
1.83809999998452E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.584200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.532400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.803600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.288200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.540100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.134980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.550400E-01 |
| Normal-vs-Grade 2 |
7.539800E-03 |
| Normal-vs-Grade 3 |
1.38949999950455E-07 |
| Normal-vs-Grade 4 |
7.73569996947998E-09 |
| Grade 1-vs-Grade 2 |
6.367900E-02 |
| Grade 1-vs-Grade 3 |
5.479600E-03 |
| Grade 1-vs-Grade 4 |
1.758230E-03 |
| Grade 2-vs-Grade 3 |
1.46369999998175E-06 |
| Grade 2-vs-Grade 4 |
1.82009999960542E-07 |
| Grade 3-vs-Grade 4 |
1.003830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.907890E-02 |
| Normal-vs-ccB subtype |
3.72679999971481E-07 |
| ccA subtype-vs-ccB subtype |
1.778830E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92397999999594E-05 |
| Normal-vs-N1 |
5.983500E-03 |
| N0-vs-N1 |
4.297400E-01 |
|
|
